Search
Londamocitinib
go.drugbank.com/drugs/DB19190InvestigationalLondamocitinib is under investigation in clinical trial NCT06020014 (Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-severe Asthma Uncontrolled on Medium-high
Synonyms: (R)-N-(3-(5-Fluoro-2-((2-fluoro-3-(methylsulfonyl)phenyl)amino)pyrimidin-4-yl)-1H-indol-7-yl)-3-methoxy-2-(4-methylpiperazin-1-yl)propanamide, 1-piperazineacetamide, n-(3-(5-fluoro-2-((2-fluoro-3-(methylsulfonyl)phenyl)amino)-4-pyrimidinyl)-1h-indol-7-yl)-.alpha.-(methoxymethyl)-4-methyl-, (.alpha.r)-Bekanamycin
go.drugbank.com/drugs/DB13673InvestigationalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseGanulameran
go.drugbank.com/drugs/DB16442InvestigationalPfizer and BioNTech deemed this compound as promising in preclinical trials and have decided to initiate further testing of it. … As such, BNT162b3 has entered a phase I/II study in early September 2020 (NCT04537949).
Tangerine peel
go.drugbank.com/drugs/DB14316InvestigationalTangerine peel is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Coconut oil
go.drugbank.com/drugs/DB14322InvestigationalCoconut oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Chondrus crispus
go.drugbank.com/drugs/DB14367InvestigationalChondrus crispus is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Remetinostat
go.drugbank.com/drugs/DB14869InvestigationalRemetinostat is under investigation in clinical trial NCT02213861 (Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma).
Moschus berezovskii musk sac resin
go.drugbank.com/drugs/DB14247InvestigationalMoschus berezovskii musk sac resin is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.
Parsaclisib
go.drugbank.com/drugs/DB14867InvestigationalParsaclisib is under investigation in clinical trial NCT03126019 (An Open-Label Study of Parsaclisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)).
Calcium silicate
go.drugbank.com/drugs/DB13829InvestigationalCategories: Drugs for Acid Related Disorders